- ALL Risk Stratification Gene Panel- B-ALL (1)
- ALL Risk Stratification Gene Panel- B-ALL
The Acute Lymphoblastic Leukemia (ALL) Risk Stratification Gene Panel for B-cell Acute Lymphoblastic Leukemia (B-ALL) is a genetic test that assesses specific genes associated with B-ALL. ALL is a type of cancer that affects the white blood cells, and B-ALL specifically involves abnormal growth of immature B-cells in the bone marrow.
By analyzing these genes and markers, the B-ALL Risk Stratification Gene Panel helps oncologists in determining the appropriate treatment plan and predicting the likelihood of treatment success for individual patients. It aids in identifying high-risk patients who may require more aggressive therapy and monitoring, as well as low-risk patients who may respond well to standard treatments.
It’s essential to note that B-ALL is a complex disease, and other factors like age, white blood cell count, and response to initial therapy are also considered in the risk stratification process.